NF type1 With Inoperable Plexiform Neurofibromas

Clinical trial pipeline · Data from ClinicalTrials.gov

See which NF type1 With Inoperable Plexiform Neurofibromas trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

APPROVED_FOR_MARKETINGNot Applicable

NCT03259633

An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1

This will be an open-label, single-arm, multicenter intermediate access protocol which provides treatment access to selumetinib for eligible patients with neuro…

United States

Treatment: Selumetinib